IP40
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as well… Read more
Market Cap & Net Worth: IP40 (IP40)
IP40 (F:IP40) has a market capitalization of $17.92 Million (€17.46 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #26980 globally and #2954 in its home market, demonstrating a -1.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IP40's stock price €3.88 by its total outstanding shares 4498772 (4.50 Million).
IP40 Market Cap History: 2026 to 2026
IP40's market capitalization history from 2026 to 2026. Data shows growth from $17.92 Million to $17.92 Million (0.00% CAGR).
IP40 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IP40's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IP40 by Market Capitalization
Companies near IP40 in the global market cap rankings as of March 18, 2026.
Key companies related to IP40 by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #35 globally with a market cap of $351.41 Billion USD.
- Unilever PLC (PINK:UNLYF): Ranked #141 globally with a market cap of $131.81 Billion USD.
- UNILEVER PLC LS -,035 (XETRA:UNV0): Ranked #147 globally with a market cap of $126.11 Billion USD ( €122.86 Billion EUR).
- L'Oréal S.A (PINK:LRLCF): Ranked #215 globally with a market cap of $94.58 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #35 | Procter & Gamble Company | NYSE:PG | $351.41 Billion | $151.48 |
| #141 | Unilever PLC | PINK:UNLYF | $131.81 Billion | $60.96 |
| #147 | UNILEVER PLC LS -,035 | XETRA:UNV0 | $126.11 Billion | €56.81 |
| #215 | L'Oréal S.A | PINK:LRLCF | $94.58 Billion | $368.10 |
IP40 Historical Marketcap From 2026 to 2026
Between 2026 and today, IP40's market cap moved from $17.92 Million to $ 17.92 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €17.92 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of IP40 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.92 Million USD |
| MoneyControl | $17.92 Million USD |
| MarketWatch | $17.92 Million USD |
| marketcap.company | $17.92 Million USD |
| Reuters | $17.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.